Macro Group Pharmaceuticals (Macro Capital)E Balance Sheet Health
Financial Health criteria checks 1/6
Macro Group Pharmaceuticals (Macro Capital)E has a total shareholder equity of EGP27.4M and total debt of EGP243.8M, which brings its debt-to-equity ratio to 891.5%. Its total assets and total liabilities are EGP517.5M and EGP490.1M respectively.
Key information
891.5%
Debt to equity ratio
ج.م243.82m
Debt
| Interest coverage ratio | n/a |
| Cash | ج.م107.28m |
| Equity | ج.م27.35m |
| Total liabilities | ج.م490.14m |
| Total assets | ج.م517.49m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MCRO's short term assets (EGP415.3M) do not cover its short term liabilities (EGP457.3M).
Long Term Liabilities: MCRO's short term assets (EGP415.3M) exceed its long term liabilities (EGP32.9M).
Debt to Equity History and Analysis
Debt Level: MCRO's net debt to equity ratio (499.2%) is considered high.
Reducing Debt: Insufficient data to determine if MCRO's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: MCRO's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if MCRO's interest payments on its debt are well covered by EBIT.